title: Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review.
abstract: Nerve growth factor (NGF) is a signalling protein that interacts with specific receptors in autocrine, paracrine and endocrine modes. It is produced by bladder smooth muscle and urothelium. Patients with overactive bladder and detrusor overactivity (DO) have been found to have increased urinary NGF levels in several small studies. The objective of the review was to assess the accuracy of NGF as a biomarker in the diagnosis of DO by a systematic review of the literature. A systematic search of MEDLINE, Embase, CINAHL, MEDION and LILACS databases was conducted (inception till December 2012). Selection criteria included studies where NGF (as a biomarker for DO) and urodynamics were performed in humans with symptoms of overactive bladder. Two reviewers independently selected articles and extracted data on study characteristics, quality and results. All the eight included studies were of case-control design. A meta-analysis was not performed as there were variations in the quality, methods of performing the NGF assay, different NGF cut-offs used and the format of reporting findings. Two studies used a cut-off of 0.05 for NGF levels. Six studies observed a trend towards higher NGF levels in patients with DO. There was a trend towards higher NGF in patients with DO. However, the data are imprecise and hence cannot be recommended for use in current clinical practice.
authors: School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, B15 2TT, UK, s.rachaneni@bham.ac.uk.
authors: S
authors: S
authors: Rachaneni
authors: P
authors: P
authors: Arya
authors: P
authors: P
authors: Latthe
mesh_terms: D015415:Biomarkers / Q000652:urine; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D020932:Nerve Growth Factor / Q000652:urine*; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D053201:Urinary Bladder, Overactive / Q000175:diagnosis* / Q000652:urine
chemical_list: D015415:Biomarkers; D020932:Nerve Growth Factor
references: BJU Int. 2008 Nov;102(10):1440-4
references: 18489524
references: Cochrane Database Syst Rev. 2012 Oct 17;10:CD008224
references: 23076941
references: J Pain. 2004 Apr;5(3):150-6
references: 15106127
references: Rev Urol. 2010 Spring;12(2-3):e69-77
references: 20811555
references: Int J Urol. 2005 Oct;12(10):875-80
references: 16323980
references: Int Urogynecol J. 2010 Jan;21(1):5-26
references: 19937315
references: Rev Urol. 2002;4 Suppl 4:S7-S18
references: 16986023
references: J Urol. 2008 Jun;179(6):2270-4
references: 18423678
references: Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5
references: 17049716
references: BMJ. 2009 Jul 21;339:b2535
references: 19622551
references: BJU Int. 2010 Dec;106(11):1681-5
references: 19751258
references: Eur J Obstet Gynecol Reprod Biol. 2001 Mar;95(1):6-11
references: 11267714
references: Can J Urol. 2010 Feb;17(1):4989-94
references: 20156378
references: Am J Med. 2006 Mar;119(3 Suppl 1):3-8
references: 16483862
references: Prog Neurobiol. 1999 Apr;57(6):583-606
references: 10221783
references: Neurourol Urodyn. 2007;26(3):405-9
references: 17266135
references: Exp Neurol. 2000 Jan;161(1):273-84
references: 10683293
references: BMC Med Res Methodol. 2003 Nov 10;3:25
references: 14606960
references: Neurourol Urodyn. 2010 Mar;29(3):482-7
references: 19367641
references: BJU Int. 2013 Mar;111(3):372-80
references: 23444927
references: Neurourol Urodyn. 2008;27(5):417-20
references: 17924444
references: Neurourol Urodyn. 2003;22(2):105-8
references: 12579626
references: J Urol. 2006 May;175(5):1773-6; discussion 1776
references: 16600756